Literature DB >> 26154001

Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

W Nicholson Price1, Timo Minssen2.   

Abstract

Mesh：

Year:  2015        PMID： 26154001     DOI： 10.1038/nbt.3243

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Preparing for responsible sharing of clinical trial data.

Authors:  Michelle M Mello; Jeffrey K Francer; Marc Wilenzick; Patricia Teden; Barbara E Bierer; Mark Barnes
Journal:  N Engl J Med       Date:  2013-10-21       Impact factor: 91.245

2.  Putting GlaxoSmithKline to the test over paroxetine.

Authors:  Peter Doshi
Journal:  BMJ       Date:  2013-11-12

3.  European drug agency backtracks on plan to give researchers access to clinical trial reports.

Authors:  Ingrid Torjesen
Journal:  BMJ       Date:  2014-05-20

4.  Clinical approval success rates for investigational cancer drugs.

Authors:  J A DiMasi; J M Reichert; L Feldman; A Malins
Journal:  Clin Pharmacol Ther       Date:  2013-06-05       Impact factor: 6.875
  4 in total
  1 in total

1.  Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe?

Authors:  Lorenz Kallenbach; Marco K Vallazza
Journal:  Nat Biotechnol       Date:  2018-10-11       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.